6-Hydroxyindolin-2-one

Catalog No.: 
ACWSXU935
CAS No.: 
6855-48-7
Molecular Formula: 
C8H7NO2
Molecular Weight: 
149.15
6-Hydroxyindolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$196.00InquiryInquiry
1g98%$400.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Hydroxyindolin-2-one
IUPAC Name6-hydroxyindolin-2-one
MDL No.MFCD05663501
Molecular FormulaC8H7NO2
Molecular Weight149.15
SMILESO=C1NC2=C(C=CC(O)=C2)C1
InChI KeyZOJZYAPVVOLQQB-UHFFFAOYSA-N
SynonymZOJZYAPVVOLQQB-UHFFFAOYSA-N | A836185 | 6-hydroxy-indoline-2-one | 6-Hydroxy-1,3-dihydro-indol-2-one, AldrichCPR | S11541 | AKOS006294204 | Q-102642 | AB21813 | BS-24632 | 6-Hydroxy-2-oxyindole | CS-0101909 | SY023129 | 1,3-DIHYDRO-6-HYDROXY-INDOL-2-ONE |
CAS No.6855-48-7
PubChem CID2784139

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWSXU935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEZXL675 route compound structure diagram
    ACEZXL6757699-19-6In Stock
  2. Then
  3. ACWSXU935 route product structure diagram
    ACWSXU9356855-48-7
Inquiry

2. ACWSXU935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXKEC540 route compound structure diagram
    ACXKEC54017641-08-6In Stock
  2. Then
  3. ACWSXU935 route product structure diagram
    ACWSXU9356855-48-7
Inquiry

3. ACWSXU935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEZXL675 route compound structure diagram
    ACEZXL6757699-19-6In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWSXU935 route product structure diagram
    ACWSXU9356855-48-7
Inquiry

Comments (0)